Prolactin and susceptibility to COVID-19 infection
- PMID: 34425453
- PMCID: PMC8353967
- DOI: 10.1016/j.mehy.2021.110662
Prolactin and susceptibility to COVID-19 infection
Keywords: COVID-19; Coronavirus; Prolactin; Smoking.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Comment on
-
Repurposing prolactin as a promising immunomodulator for the treatment of COVID-19: Are common Antiemetics the wonder drug to fight coronavirus?Med Hypotheses. 2020 Nov;144:110208. doi: 10.1016/j.mehy.2020.110208. Epub 2020 Aug 24. Med Hypotheses. 2020. PMID: 33254515 Free PMC article.
References
-
- Fuxe K., Andersson K., Eneroth P., Härfstrand A., Agnati L.F. Neuroendocrine actions of nicotine and of exposure to cigarette smoke: medical implications. Psychoneuroendocrinology. 1989;14(1-2):19–41. - PubMed
-
- Coleman D.T., Bancroft C. Nicotine acts directly on pituitary GH3 cells to inhibit prolactin promoter activity. J Neuroendocrinol. 1995;7(10):785–789. - PubMed
-
- Kapoor D., Jones T.H. Smoking and hormones in health and endocrine disorders. Eur J Endocrinol. 2005;152(4):491–499. - PubMed